Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Is It Truly "Alpha"? Incidence of Thrombotic Events With Andexanet Alfa at a Single Academic Medical Center.

Tytuł:
Is It Truly "Alpha"? Incidence of Thrombotic Events With Andexanet Alfa at a Single Academic Medical Center.
Autorzy:
Parsels KA; Department of Pharmacy, Upstate University Hospital, Syracuse, NY.
Seabury RW; Department of Pharmacy, Upstate University Hospital, Syracuse, NY; Department of Medicine, Upstate Medical University, Syracuse, NY; Upstate Pharmacy Services Translational Research Team (UPSTART).
Darko W; Department of Pharmacy, Upstate University Hospital, Syracuse, NY; Department of Medicine, Upstate Medical University, Syracuse, NY; Upstate Pharmacy Services Translational Research Team (UPSTART).
Probst LA; Department of Pharmacy, Upstate University Hospital, Syracuse, NY; Department of Medicine, Upstate Medical University, Syracuse, NY; Upstate Pharmacy Services Translational Research Team (UPSTART).
Cwikla GM; Department of Pharmacy, Upstate University Hospital, Syracuse, NY; Department of Medicine, Upstate Medical University, Syracuse, NY; Upstate Pharmacy Services Translational Research Team (UPSTART).
Miller CD; Department of Pharmacy, Upstate University Hospital, Syracuse, NY; Department of Medicine, Upstate Medical University, Syracuse, NY; Upstate Pharmacy Services Translational Research Team (UPSTART).
Źródło:
Annals of emergency medicine [Ann Emerg Med] 2020 May; Vol. 75 (5), pp. 675-676.
Typ publikacji:
Letter
Język:
English
Imprint Name(s):
Publication: St. Louis, MO : Mosby
Original Publication: [Lansing, Mich., American College of Emergency Physicians]
MeSH Terms:
Factor Xa/*administration & dosage
Factor Xa Inhibitors/*administration & dosage
Hemorrhage/*drug therapy
Recombinant Proteins/*administration & dosage
Thrombosis/*chemically induced
Drug Administration Schedule ; Factor Xa/adverse effects ; Factor Xa Inhibitors/adverse effects ; Humans ; Incidence ; Recombinant Proteins/adverse effects
Substance Nomenclature:
0 (Factor Xa Inhibitors)
0 (PRT064445)
0 (Recombinant Proteins)
EC 3.4.21.6 (Factor Xa)
Entry Date(s):
Date Created: 20200428 Date Completed: 20200513 Latest Revision: 20200513
Update Code:
20240105
DOI:
10.1016/j.annemergmed.2019.12.026
PMID:
32336435
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies